Curriculum Vitae Robert S. Haber, MD

October 2, 2019

1

CONTACT INFORMATION Robert S. Haber, MD, President 2002-Present Haber Dermatology, Inc. 26949 Chagrin Blvd. STE 300 Beachwood, Ohio 44122 Phone: (216) 932-5200 Fax # (216) 803-2205 _________________________ ___________ E-mail: Haberdoc3@gmail.com Robert Haber, MD Date ACADEMIC APPOINTMENTS CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE University Hospitals of Cleveland, Cleveland, Ohio Clinical Associate Professor of Dermatology and Pediatrics 2009-Present Clinical Assistant Professor of Dermatology and Pediatrics 2006-2009 Assistant Professor of Dermatology and Pediatrics 1994-2006 Director, Pediatric Dermatology 1994-2004 OHIO COLLEGE OF PODIATRIC MEDICINE Department of General Medicine, Cleveland, Ohio Instructor of Dermatology 1991-1992 HOSPITAL APPOINTMENTS

CURRENT DEPARTMENTS CATEGORY DATES University Hospitals of Cleveland Cleveland, Ohio

Dermatology Pediatrics

Active Active

1994-Present 1994-Present

Parma General Community Hospital Parma, Ohio Medicine Consulting 1994-Present

Summa Health System Akron, Ohio

Medicine Division of Dermatology

Affiliate- Non-Admit 2001-Present

Akron General Medical Center Akron, Ohio Medicine Consulting 2001-2010

PREVIOUS Metro Health Medical Center Cleveland, Ohio Dermatology Affiliate-

Provisional 2000-2007

St. Joseph's Regional Health Center Hot Springs, Arkansas Surgery Active 1993-1994

AMI Medical Center Hot Springs, Arkansas Medicine Courtesy 1993-1994

Hot Springs County Memorial Hospital Malvern, Arkansas General Consulting 1993-1994

RESIDENCIES AND FELLOWSHIPS THE STOUGH CLINIC 7/93-6/94 Hot Springs, Arkansas Fellowship, Dermatologic Cosmetic Surgery and Hair Restoration Surgery UNIVERSITY HOSPITALS OF CLEVELAND 7/90-6/93 Cleveland, Ohio

Dermatology Residency

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

2

NEW YORK UNIVERSITY MEDICAL CENTER 7/89-6/90 New York, New York Fellowship, Dermatopharmacology ALBERT EINSTEIN COLLEGE OF MEDICINE 7/86-6/89 Bronx, New York Pediatric Internship, Pediatric Residency EDUCATION ALBANY MEDICAL COLLEGE 9/82-5/86 Albany, New York M.D. - 5/86 SYRACUSE UNIVERSITY 9/77-5/81 Syracuse, New York B.S. - 5/81 (Psychology) Honors AWARDS AND HONORS

Golden Follicle Award- International Society of Hair Restoration Surgery 2009

Caesar Award- Italian Society of Hair Restoration 2007

Ghirlandina Award- Italian Society of Hair Restoration 2005

Rome Award for Ethics in Hair Restoration- Italian Society of Hair Restoration 2003

Michelangelo Award- Italian Society of Hair Restoration 2002

Voted One of Ohio’s Top Doctors- Northern Ohio Live Magazine 2001

First International Archimedes Award- Italian Society of Hair Restoration 2001

Accepted as Life Member, National Registry of Who’s Who 1999

Research Grant Award- International Society of Hair Restoration Surgery 1998

Surgeon of the Month- Hair Transplant Forum International 1998

Hair Restoration Surgeon of the Year- Consumer Business Review 1997

Excellence in Resident Teaching Award-

Dermatology Residents- University Hospitals of Cleveland 1996

Research Grant Award- International Society of Hair Restoration Surgery 1994

Award of Excellence- International Society of Hair Restoration Surgery 1994

Special Senior Student Award- Albany Medical College 1986

Syracuse University - cum laude 1981 MEMBERSHIPS IN PROFESSIONAL SOCIETIES

Fellow- American Academy of Dermatology

Fellow- American Academy of Pediatrics

Fellow- American Academy of Cosmetic Surgery

Fellow- American Society for Mohs Surgery

Member- American Medical Association

Member- Cleveland Dermatological Association

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

3

Member- Ohio Dermatological Association

Member- American Society for Dermatologic Surgery

Member- Ohio Society for Dermatologic Surgery

Member- Academy of Medicine of Cleveland

Member- International Society of Hair Restoration Surgery

Member- Society for Pediatric Dermatology

Member- Section on Dermatology, American Academy of Pediatrics

Member- European Society of Hair Restoration Surgery OFFICES IN PROFESSIONAL SOCIETIES President International Society of Hair Restoration Surgery 2002 - 2003 Chairman Global Council of Hair Restoration Surgery Societies 2002 - 2003 Vice President International Society of Hair Restoration Surgery 2001 - 2002 Treasurer International Society of Hair Restoration Surgery 1999 - 2001

Board of Governors International Society of Hair Restoration Surgery 1998 - 2004 2009 - 2011 2013 - 2015 LICENSURE AND BOARD CERTIFICATION Cert. # Issued Recert Recert Expires

Ohio State License #64474 12/92 10/16

New York State License #173287 3/88 Inactive

Arkansas State License #N8354 6/93 3/95

Diplomat, American Board of Dermatology N.A. 10/94 6/03 4/14 12/24

Diplomat, American Board of Pediatrics #42532 10/89 6/97 4/02 12/16

Diplomat, National Board of Medical Examiners #327283 7/87 N.A.

Good Clinical Practice Certification (GCP) 1/7/2014 1/7/2017

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

4

COMMITTEE AND ADMINISTRATIVE SERVICE Editor, Hair Transplant Forum International International Society of Hair Restoration Surgery 2005-2008 Chairman, Ad Hoc Committee on Residency Programs International Society of Hair Restoration Surgery 2005-2007

Strategic Task Force on Practice Guidelines and Physician Recognition International Society of Hair Restoration Surgery 2005-2008 Strategic Task Force on Training Initiative International Society of Hair Restoration Surgery 2005-2008 Chairman, Task Force on Hair Transplant CPT Codes International Society of Hair Restoration Surgery 2004-Present Chairman, Past-President’s Committee International Society of Hair Restoration Surgery 2004-2005 Nominating Committee International Society of Hair Restoration Surgery 2004-2005 Chairman, Audit Committee International Society of Hair Restoration Surgery 2004-2009 Committee on Standard of Care and Core Curriculum Development International Society of Hair Restoration Surgery 2002-2004 Committee on Continuing Medical Education International Society of Hair Restoration Surgery 2002-Present

Melanoma/Skin Cancer Committee American Academy of Dermatology 2001-2005 Live Surgery Workshop Committee International Society of Hair Restoration Surgery 2001-2004 Pro Bono Foundation Committee International Society of Hair Restoration Surgery 2001-2008

Ad Hoc Certification Committee International Society of Hair Restoration Surgery 2001-2002 Participant American Academy of Dermatology Washington Conference 2000 Program Chairman - Annual Meeting International Society of Hair Restoration Surgery 1997 Workshop Coordinator - Annual Meeting International Society of Hair Restoration Surgery 1996 Fellowship Training Committee International Society of Hair Restoration Surgery 1996 - 1998 Annual Meeting Committee International Society of Hair Restoration Surgery 1995 - 1998

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

5

Workshop Coordinator - Annual Meeting

International Society of Hair Restoration Surgery 1995 Computer Committee Department of Dermatology University Hospitals of Cleveland 1995 - 1997 Medical Records Committee University Hospitals of Cleveland 1994 - 2006 EDUCATIONAL ACTIVITIES Medical Student Teaching - Clinical Pediatric Dermatology 1994 - Present Individual Names Available Resident Teaching - Clinical Pediatric Dermatology 1994 - Present Individual Names Available SCIENTIFIC ACTIVITIES Editor 2005-2008 Hair Transplant Forum International JOURNAL REVIEWER Journal of Cosmetic Dermatology 2007-Present Journal of Dermatologic Surgery 1996 Journal of the American Academy of Dermatology 1995 Neurology 1995 BIBLIOGRAPHY TEXTBOOKS

1. Haber RS, Stough D. Hair Transplantation. China: Elsevier Saunders, 2006.

2. Stough D, Haber RS. Hair Replacement: Surgical and Medical. St. Louis: Mosby Year Book Publishing Company, 1996.

TEXTBOOK CHAPTERS

1. Haber RS. Effect of Medical Therapy on Planning for Hair Restoration Surgery. In Unger W, Shapiro R, eds. Hair Transplantation. Fifth Edition, Informa Healthcare, New York, 2011.

2. Haber RS. The “Spreader:” Technique and Indications. In Unger W, Shapiro R, eds. Hair Transplantation. Fifth Edition, Informa Healthcare, New York, 2011.

3. Haber RS. Alopecia. In Loue S, Sajatovic M, eds. The Encyclopedia of Aging and Public Health. Springer, New York, 2008.

4. Haber RS. Hair replacement. In Loue S, Sajatovic M, eds. The Encyclopedia of Aging and Public Health. Springer, New York, 2008

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

6

5. Haber RS. Pathogenesis and medical therapy of male and female pattern hair loss. In Haber RS, Stough D. Hair Transplantation. Elsevier, China 2006.

6. Haber RS. Standardized photography for hair restoration surgery. In Stough D, Haber RS, eds. Hair Replacement: Surgical and Medical. St. Louis: Mosby Year Book Publishing Company, 1996.

7. Haber RS, Stough D. Accurate estimation of graft requirements when utilizing multibladed knives In Stough D,

Haber RS, eds. Hair Replacement: Surgical and Medical. St. Louis: Mosby Year Book Publishing Company, 1996.

8. Haber RS, Stough D. The postoperative dressing. In Stough D, Haber RS, eds. Hair Replacement: Surgical and

Medical. St. Louis: Mosby Year Book Publishing Company, 1996. 9. Haber RS, Kahn SH. Nerve block anesthesia of the scalp. In Stough D, Haber RS, eds. Hair Replacement:

Surgical and Medical. St. Louis: Mosby Year Book Publishing Company, 1996. 10. Stough D, Haber RS. The donor site. In Stough D, Haber RS, eds. Hair Replacement: Surgical and Medical. St.

Louis: Mosby Year Book Publishing Company, 1996. ONLINE PUBLICATIONS

1. Haber RS. Androgenetic alopecia. In Best Practice, BMJ Evidence Centre, London, 2012. ORIGINAL REPORTS

2. Puig CJ, Beehner ML, Cotterill PC, Elliott VW, Haber RS, et al. Core competencies for hair restoration surgeons recommended by the International Society of Hair Restoration Surgery. Dermatol Surg 35:425–428, 2009.

3. Stough D, Stenn K, Haber RS, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. Oct;80(10):1316-22, 2005.

4. Haber RS. Pharmacologic management of pattern hair loss. Facial Plast Surg Clin N Am 12:181-189, 2004.

5. Avram M, Cole J, Gandelman M, Haber RS, et al. The potential role of minoxidil in the hair transplant setting.

Dermatol Surg 28:894-900, 2002.

6. Haber RS. Dutasteride for androgenetic alopecia- words of caution (letter). Hair Transplant Forum International 12:35-36, 2002.

7. Haber RS. Octylcyanoacrylate tissue adhesive vs. Staples for donor site closure in hair restoration surgery. Cosmetic Dermatology 12:33-36, 1999.

8. Haber RS. The argument against board certification (letter). Hair Transplant Forum International 9:33-36, 1999.

9. Bernstein RM, Rassman WR, Seager D, Shapiro R, Cooley JE, Norwood OT, Stough DB, Beehner M, Arnold J, Limmer BL, Avram MR, McClellan RE, Rose PT, Blugerman G, Gandelman M, Cotterill PC, Haber R, Jones R, Vogel JE, Moy RL, Unger WP. Standardizing the classification and description of follicular unit transplantation and mini-micrografting techniques. Dermatol Surg 24:957-963, 1998.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

7

10. Haber RS. On developmental milestones (letter). Pediatrics 102:884, 1998.

11. Haber RS. Photographic protocols for hair restoration surgery. Int J Aesth and Restor Surg 3:89-92, 1995.

12. Haber RS. Accutane precautions (letter). Fitzpatrick’s J Clin Dermatol May/June:9, 1994.

13. Wood GS, Haber RS. Novel histiocytoses considered in the context of histiocyte subset differentiation (editorial review). Arch Dermatol 129:210-214, 1993.

14. Shupack JL, Stiller MJ, Haber RS. AIDS and the skin: Psoriasis and Reiter's syndrome. Clin Dermatol 9:53-58, 1991.

15. Conway EE, Haber RS, Gumprecht J, Singer LP. Toxic shock syndrome following Influenza A in a child. Crit Care Med 19:123-125, 1991.

16. Shupack JL, Haber RS, Stiller MJ. The future of topical therapy for cutaneous aging. J Dermatol Surg Oncol 16:941-944, 1990.

17. Held JL, Haber RS, Silvers DN, Grossman ME. Benign neonatal hemangiomatosis: review and description of a patient with unusually persistent lesions. Pediatr Dermatol 7:63-6, 1990.

18. Haber RS, Beltrani VP, Yunakov MJ, Held JL. Basal cell carcinoma of the scalp in a black patient. Cutis 44: 59-60, 1989

POSTERS AND ABSTRACTS

1. Haber RS, Stough D. Accurate estimation of hair transplant graft requirements. Presented at the American Academy of Dermatology Meeting. New Orleans: February 1995.

2. Haber RS, Stough D. Single hair grafting: the final frontier. Presented at the American Academy of Dermatology

Meeting. Washington, D.C: December 1993. 3. Stiller M, Shupack J, Davis I, Wachsman S, Haber R, Kenny C, Jondreau L. Elevation of blood lipids in patients

treated with low dose cyclosporine for severe recalcitrant plaque-type psoriasis. Presented at the Skin Pharmacology Society Meeting. June 20-22, 1991.

4. Shupack JL, Stiller MJ, Thaler S, Frey J, Cooper D, Haber RS. Acceleration of wound healing by a portable

pulsed electromagnetic field (PEMF) device. J Invest Dermatol 96:570A, 1991. SEMINARS, LECTURES, AND PRESENTATIONS

1. Haber RS. Live surgery demonstration of hairline design and recipient site creation. Presented to attendees at The Next Big Thing: Hair Research and Advanced Live Surgery Workshop, Istanbul, Turkey May 13-15, 2011.

2. Haber RS. The growing role of low level laser therapy in hair restoration. Presented to attendees at The Next Big Thing: Hair Research and Advanced Live Surgery Workshop, Istanbul, Turkey May 13-15, 2011.

3. Haber RS. Density definition in modern hair transplantation. Presented to attendees at The Next Big Thing: Hair Research and Advanced Live Surgery Workshop, Istanbul, Turkey May 13-15, 2011.

4. Haber RS. Open Mic Session Moderator. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting, Boston: October 20-24, 2010.

5. Haber RS. Review of scalp and hair follicle anatomy & physiology. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting, Boston: October 20-24, 2010.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

8

6. Haber RS. Introduction of a novel laser based device for hair growth and protocol for scientific analysis. Presented to attendees at the 4th Brazilian Congress of Hair Restoration, Belo Horizonte, Brazil: August 18-21, 2010

7. Haber RS. Moderator, eyebrow, eyelash, and pubic hair transplantation. Presented to attendees at the 4th Brazilian Congress of Hair Restoration, Belo Horizonte, Brazil: August 18-21, 2010

8. Haber RS. Principles of hair restoration and scalp anatomy. Presented to attendees at the Hair Restoration Surgery Hands-On Cadaver Workshop, St. Louis, MO: July 23 - 25, 2010.

9. Haber RS. Hairline design. Presented to attendees at the Hair Restoration Surgery Hands-On Cadaver Workshop, St. Louis, MO: July 23 - 25, 2010.

10. Haber RS. Eyebrow transplant principles and strategies. Presented to attendees at the Hair Restoration Surgery Hands-On Cadaver Workshop, St. Louis, MO: July 23 - 25, 2010.

11. Haber RS. “Non-Virgin” donor harvest strategies. Presented to attendees at the Hair Restoration Surgery Hands-On Cadaver Workshop, St. Louis, MO: July 23 - 25, 2010.

12. Haber RS. Managing complications. Presented to attendees at the Hair Restoration Surgery Hands-On Cadaver Workshop, St. Louis, MO: July 23 - 25, 2010.

13. Haber RS. A multiblade depth limiting scoring device. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting, Amsterdam: July 22-26, 2009.

14. Haber RS. Moderator, Potpourri. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting, Amsterdam: July 22-26, 2009.

15. Haber RS. Single vs double layer closure. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting, Amsterdam: July 22-26, 2009.

16. Haber RS. Maximizing yield and minimizing transection during the donor harvest. Presented to attendees at the III Brazilian Congress of Hair Restoration Surgery. Rio de Janeiro, Brazil: October 16-18, 2008

17. Haber RS. Panelist. Controversy session, The Trichophytic Closure. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. Montreal: September 3-7, 2008.

18. Haber RS. Moderator, Live Video Surgery Theatre. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. Montreal: September 3-7, 2008.

19. Haber RS. Faculty, Hairline workshop. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. Montreal: September 3-7, 2008.

20. Haber RS. Principal Surgeon- Live demonstration of female hair transplant. Presented to conference attendees at the ISHRS Regional Workshop: Made in Italy Hair Restoration Live Video Workshop. Rome, Italy: May 30-June 1, 2008.

21. Haber RS. Overview of hair restoration surgery. Presented to Dermatology Residents at the University Hospitals of Cleveland Department of Dermatology Clinical Conference. Cleveland: January 24, 2008.

22. Haber RS. Moderator, Live Surgery Theatre. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. Las Vegas: September 26-30, 2007.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

9

23. Haber RS. Tissue spreader: Analysis of transection reduction. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. Las Vegas: September 26-30, 2007.

24. Haber RS. Tissue spreader: Analysis of transection reduction. Presented to attendees at the Italian Society of Hair Restoration Annual Meeting. Milan: June 1, 2007.

25. Haber RS. Tissue spreader: Analysis of transection reduction. Presented to attendees at the European Society of Hair Restoration Surgery Annual Meeting. Paris: May 25, 2007.

26. Haber RS. Principal Surgeon- Live demonstration of tissue spreader. Presented to conference attendees at the European Society of Hair Restoration Surgery Annual Meeting. Paris: May 25, 2007.

27. Haber RS. Hair restoration surgery. Presented to attendees at the Northern Ohio Academy of Pharmacy Morning Seminar. Cleveland: April 25, 2007.

28. Haber RS. Hair transplant update: 2007. Presented to attendees at the American Academy of Dermatology Annual Meeting. Washington, D.C.: February 2-6, 2007.

29. Haber RS. Harvesting the donor strip for maximum yield. Presented to attendees at the American Society of Hair Restoration Surgery Annual Meeting. Phoenix: January 24, 2007.

30. Haber RS. Modern principles of hair restoration surgery. Presented to Dermatology Residents at the University Hospitals of Cleveland Department of Dermatology Clinical Conference. Cleveland: December 4, 2006.

31. Haber RS. Panelist. Patient evaluation and selection. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Diego: October 18-23, 2006.

32. Haber RS. Anesthetics and other medications for hair restoration. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Diego: October 18-23, 2006.

33. Haber RS. Director, Ergonomics workshop. Principles and pearls. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Diego: October 18-23, 2006.

34. Haber RS. Faculty, Hairline and crown workshop. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Diego: October 18-23, 2006.

35. Haber RS. Safe donor harvesting. An update on the spreader. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Diego: October 18-23, 2006.

36. Haber RS. Moderator, Live surgery workshop. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Diego: October 18-23, 2006.

37. Haber RS. Harvesting high quality strips with minimal transection. Presented to conference attendees at the European Society of Hair Restoration Surgery Annual Meeting. Zurich, Switzerland: May 25-28, 2006.

38. Haber RS. Team Surgeon- Live demonstration of follicular unit transplantation on female patient. Presented to

conference attendees at the ISHRS Live Surgery Workshop. Orlando, Florida: March 15-18, 2006.

39. Haber RS. Principal Surgeon- Live demonstration of tissue spreader. Presented to conference attendees at the ISHRS Live Surgery Workshop. Orlando, Florida: March 15-18, 2006.

40. Haber RS. Session Moderator- New devices and instruments in hair restoration surgery. Presented to conference attendees at the ISHRS Live Surgery Workshop. Orlando, Florida: March 15-18, 2006.

41. Haber RS. The tissue spreader- a new device to minimize donor transection. Presented to conference attendees at the ISHRS Live Surgery Workshop. Orlando, Florida: March 15-18, 2006.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

10

42. Haber RS. A new delivery vehicle for minoxidil. Presented to conference attendees at the ISHRS Live Surgery Workshop. Orlando, Florida: March 15-18, 2006.

43. Haber RS. A new device for efficient strip harvesting. Presented to conference attendees at the International Society of Hair Restoration Surgery Annual Meeting. Sydney, Australia: August 24-28, 2005.

44. Haber RS. Recent advances in hair restoration. Presented to conference attendees at the International Society of Hair Restoration Surgery Annual Meeting. Sydney, Australia: August 24-28, 2005.

45. Haber RS. Session moderator. Female hair loss. International Society of Hair Restoration Surgery Annual Meeting. Sydney, Australia: August 24-28, 2005.

46. Haber RS. A new device to minimize donor transection. Presented to conference attendees at the Italian Society

of Hair Restoration Meeting. Modena, Italy: June 2-4, 2005.

47. Haber RS. The all important initial consultation. Presented to conference attendees at the American Academy of Dermatology Meeting. Washington, DC: February 2004.

48. Haber RS. Presidents Address. The state of our profession: seeking to simplify, yet becoming more complex.

Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. New York: October 15-19, 2003.

49. Haber RS. The state of our profession: seeking to simplify, yet becoming more complex Presented to conference

attendees at the European Society of Hair Restoration Surgery Annual Meeting, May 29-Jun 1, 2003. 50. Haber RS. Maximizing the esthetic ideal in hair restoration. Presented to conference attendees at the Italian

Society of Hair Restoration Meeting. Rome, Italy: May 25-27, 2003. 51. Haber RS. Nerve blocks, donor site harvesting and closure, follicular unit micrografting. Live surgical

demonstration to conference attendees at the Guadalajara Masters Meeting. Guadalajara: February 28-March 3, 2003.

52. Haber RS. Panelist. How we incorporate finasteride into our practice. Presented to attendees at the International

Society of Hair Restoration Surgery Annual Meeting. Chicago: October 9-13, 2002. 53. Haber RS. Session moderator. Road blocks to hair loss. International Society of Hair Restoration Surgery Annual

Meeting. Chicago: October 9-13, 2002. 54. Haber RS. Emerging pharmacologic allies in the hair loss war. Presented to attendees at the International Society

of Hair Restoration Surgery Annual Meeting. Chicago: October 9-13, 2002.

55. Haber RS. New Therapies in Atopic Dermatitis. Presented to attendees at an Advisory Board Meeting. Cleveland: August 1, 2002. Sponsor: Novartis Pharmaceuticals.

56. Haber RS. Session Moderator, Complications. European Society of Hair Restoration Surgery Annual Meeting,

London: June 6-9, 2002. 57. Haber RS. The role of finasteride in the hair restoration practice. Presented to conference attendees at the

European Society of Hair Restoration Surgery Annual Meeting, London: June 6-9, 2002. 58. Haber RS. The controversial role of artificial hair in hair restoration. Presented to conference attendees at the

Italian Society of Hair Restoration Meeting. Florence, Italy: June 5, 2002.

59. Haber RS. New Therapies in Atopic Dermatitis. Presented to attendees at a Roundtable Discussion Meeting. Cleveland: May 23, 2002. Sponsor: Novartis Pharmaceuticals.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

11

60. Haber RS. The role of finasteride in the treatment of androgenetic alopecia. Presented to attendees at a Roundtable Discussion Meeting. Cleveland: April 25, 2002. Sponsor: Merck Pharmaceuticals.

61. Haber RS. Diagnosis and management of eczema and atopic dermatitis in children. Presented to attendees at

Rainbow Babies & Children’s Hospital Teaching Grand Rounds, Cleveland: April 24, 2002.

62. Haber RS. The role of finasteride in the hair restoration practice. Presented to attendees at a Roundtable Discussion Meeting. Worcester, Mass: March 19, 2002. Sponsor: Merck Pharmaceuticals.

63. Haber RS. Panelist, Medicine and hair transplantation. Presented to conference attendees at the ISHRS Live

Surgery Workshop. Orlando: March 6-9, 2002. 64. Haber RS. Panelist, Recipient sites in hair restoration surgery. Presented to conference attendees at the

International Society of Hair Restoration Surgery Live Surgery Workshop. Orlando: March 6-9, 2002. 65. Haber RS. Session Moderator, Special considerations in hair restoration. International Society of Hair Restoration

Surgery Live Surgery Workshop. Orlando: March 6-9, 2002. 66. Haber RS. Total micrografting using follicular units and microslits. Live surgical demonstration to conference

attendees at the International Society of Hair Restoration Surgery Live Surgery Workshop. Orlando: March 6-9, 2002.

67. Haber RS. Pigmented nevi and melanoma in children. Presented to attendees at Rainbow Babies & Children’s Hospital Teaching Grand Rounds, Cleveland: January 16, 2002.

68. Haber RS. The role of finasteride in hair restoration surgery. Presented to Dermatologists at the Ohio

Dermatological Association Annual Meeting. Columbus: November 16-17, 2001.

69. Haber RS. Session Moderator, Ideas and controversies. International Society of Hair Restoration Surgery Annual Meeting. Puerto Vallarta, Mexico: October18-22, 2001.

70. Haber RS. Session Moderator, Open microphone. International Society of Hair Restoration Surgery Annual Meeting. Puerto Vallarta, Mexico: October18-22, 2001.

71. Haber RS. Session Moderator, Managing the hair transplant patient with pharmacological treatments: pre & post surgery. Advisory Meeting. Puerto Vallarta, Mexico: October 17, 2001. Sponsor: Pharmacia Corporation.

72. Haber RS. Managing expectations and patient outcomes in the treatment of androgenetic alopecia. Presented to attendees at a Roundtable Discussion Meeting. Los Angeles, California: June 8, 2001. Sponsor: Merck Pharmaceuticals.

73. Haber RS. Managing expectations and patient outcomes in the treatment of androgenetic alopecia. Presented to attendees at a Roundtable Discussion Meeting. Costa Mesa, California: June 7, 2001. Sponsor: Merck Pharmaceuticals.

74. Haber RS. Megasession magic- how to make the leap. Presented to conference attendees at the Italian Society of Hair Restoration Meeting. Syracusa, Sicily: May 24-27, 2001.

75. Haber RS. New advances in medical and surgical treatment of hair loss. Presented to Dermatology Residents at a Roundtable Discussion Meeting. Cleveland: January 25, 2001. Sponsor: Merck Pharmaceuticals.

76. Haber RS. Session Moderator, Scientific Session IV: Lasers in hair restoration surgery. International Society of

Hair Restoration Surgery Annual Meeting. Hawaii: November 30-December 4, 2000.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

12

77. Haber RS. Fungal infections and atopic dermatitis. Presented to attendees at Rainbow Babies & Children’s Hospital Teaching Grand Rounds, Cleveland: May 24, 2000.

78. Haber RS. Medical and surgical management of hair loss. Presented to attendees at the Ohio Dermatology

Nursing Association Spring Meeting. Cleveland: May 6, 2000.

79. Haber RS. Finasteride: the American experience. Presented to conference attendees at the Italian Society of Hair Restoration Meeting. Rome: January 12-17, 2000.

80. Haber RS. Hair restoration: Hot tips for the new millennium. Presented to conference attendees at the Italian

Society of Hair Restoration Meeting. Rome: January 12-17, 2000. 81. Haber RS. Session Moderator, Scientific Session I: A potpourri of useful ideas for the hair replacement surgeon.

International Society of Hair Restoration Surgery Annual Meeting. San Francisco: October 20-24, 1999.

82. Haber RS. Session Moderator, Clinical/Surgical Pearls Session. International Society of Hair Restoration Surgery Annual Meeting. Washington, D.C.: September 16-20, 1998.

83. Haber RS. The use of a tissue adhesive for closing the donor site. Presented to attendees at the International Society of Hair Restoration Surgery Annual Meeting. San Francisco: October 20-24, 1999.

84. Haber RS. Evaluation of pigmented and vascular lesions in children. Presented to attendees at the Ohio Dermatology Nursing Association Fall Meeting. Columbus: September 25, 1999.

85. Haber RS. New techniques in hair restoration. Presented to attendees at the Akron Journal Club. Akron: July 20, 1999.

86. Haber RS. Medical and surgical management of hair loss. Presented to attendees at the Dermatology Update for at the Chautaqua Institution Conference. Chautaqua: July 2, 1999.

87. Haber RS. How to diagnose and treat patients with hair loss. Presented to attendees at the Dermatology Update for Primary Care Physicians Conference. Akron: April 21, 1999.

88. Haber RS. Advanced concepts in pediatric dermatology. Presented to conference attendees at the Fairview Hospital Pediatric Grand Rounds. Cleveland: March 19, 1999.

89. Haber RS. Comparative study of micrografting using follicular units and microslits vs. needle sites with dilators, the Rassman Implanter, and the Choi implanter. Live surgical demonstration to conference attendees at the World Society of Hair Restoration Surgery Meeting. Orlando: March 4-9, 1998.

90. Haber RS. Advanced concepts in pediatric dermatology. Presented to conference attendees at the Rainbow Babies & Children’s Hospital Pediatric Grand Rounds. Cleveland: January 21, 1999.

91. Haber RS. Pediatric Dermatology. Presented to Dermatology Residents at the University Hospitals of Cleveland Department of Dermatology Clinical Conference. Cleveland: December 30, 1998.

92. Haber RS. Current concepts in pediatric dermatology. Presented to attendees at the Meridia-Hillcrest Pediatric Conference. Cleveland: November 6, 1998.

93. Haber RS. Cherish or Perish: The critical role of the medical assistant. Presented to conference attendees at the International Society of Hair Restoration Surgery Annual Meeting. Washington, D.C.: September 16-20, 1998.

94. Haber RS. Megasession Workshop. Presented to conference attendees at the International Society of Hair

Restoration Surgery Annual Meeting. Washington, D.C.: September 16-20, 1998. 95. Haber RS. My worst complication. Presented to conference attendees at the International Society of Hair

Restoration Surgery Annual Meeting. Washington, D.C.: September 16-20, 1998.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

13

96. Haber RS. Dermabond (octylcyanoacrylate) tissue adhesive vs. staples for donor site closure. Presented to conference attendees at the International Society of Hair Restoration Surgery Annual Meeting. Washington, D.C.: September 16-20, 1998.

97. Haber RS. Total micrografting: a new treatment for hair loss. Presented to attendees at the Community Talk,

University Suburban Health Center. Cleveland: July 29, 1998.

98. Haber RS. Density vs. the natural look: the microslit solution. Presented to conference attendees at the Italian Society of Hair Restoration Meeting. Rome: May 21-24, 1998.

99. Haber RS. Micrografting with follicular units and microslits. Presented to conference attendees at the Italian

Society of Hair Restoration Meeting. Rome: May 21-24, 1998.

100. Haber RS. Non-surgical skin rejuvenation. Presented to attendees of the Health Museum of Cleveland You Look Marvelous program. Cleveland: May 2, 1998.

101. Haber RS. Micrografting using follicular units and microslits- The Cleveland technique. Presented to conference

attendees at the World Society of Hair Restoration Surgery Meeting. Orlando: March 4-9, 1998.

102. Haber RS. The medical and surgical treatment of hair loss. Presented to Family Practice practitioners at a Roundtable Discussion Meeting. Vermillion, Ohio: November 18, 1997. Sponsor: Merck Pharmaceuticals.

103. Haber RS. Session Moderator, Controversies Session: Debates. International Society of Hair Restoration Surgery Annual Meeting. Barcelona, Spain: October 15-19, 1997.

104. Haber RS. Advances in hair replacement. Presented to Dermatologists at the Ohio Dermatological Association Annual Meeting. Columbus: September 26-28, 1997.

105. Haber RS. Clinical photography: what the Dermatologist needs to know. Presented to Dermatology Residents at

the University Hospitals of Cleveland Department of Dermatology Clinical Conference. Cleveland: August 20, 1997.

106. Haber RS. Childhood skin disorders: what the Family Practitioner needs to know. Presented to Family Practice

Residents at University Hospitals of Cleveland, Clinical Conference. Cleveland: August 19, 1997. 107. Haber RS. Office photography tips for the hair restoration surgeon. Presented to conference attendees at the

Italian Society of Hair Restoration Meeting. Rome: June 6-8, 1997. 108. Haber RS. The microslit approach to hair restoration surgery. Presented to conference attendees at the Italian

Society of Hair Restoration Meeting. Rome: June 6-8, 1997. 109. Haber RS. Update on treatment of eczema. Presented to Pediatricians at the Rainbow Babies and Children’s

Hospital, Pediatrics Today Conference. Cleveland: February 25, 1997. 110. Haber RS. Eczema and Atopic Dermatitis. Presented to Pediatric Residents at Teaching Grand Rounds,

Cleveland: October 2, 1996. 111. Haber RS. Should alopecia reductions be performed at all? Presented to conference attendees at the International

Society of Hair Restoration Surgery Meeting. Nashville: September 15-18, 1996. 112. Haber RS. Hair transplantation in the young patient. Presented to conference attendees at the International

Society of Hair Restoration Surgery Meeting. Nashville: September 15-18, 1996. 113. Haber RS. Management of severe atopic dermatitis in children. Presented to conference attendees at the

American Academy of Dermatology Summer Meeting. Orlando: July 1996.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

14

114. Haber RS. Basic topics in hair restoration: the consultation, anatomy, photography, medico-legal issues, local anesthesia, nerve blocks. Presented to conference attendees at the American Academy of Dermatology Summer Meeting. Orlando: July 1996.

115. Haber RS. Pediatric Dermatology for the Pediatrician. Presented to Pediatric Residents at Teaching Grand

Rounds, Cleveland: May 23, 1996.

116. Haber RS. Update in Pediatric Dermatology. Presented to primary care physicians at the University Primary Care Physician Practices Conference, Cleveland: April 24, 1996.

117. Haber RS. Pediatric dermatology- common conditions. Presented to conference attendees at Medicine Fall 1995

Conference, Cleveland: November 15, 1995. 118. Haber RS. Setting up the hair restoration surgical suite. Presented to conference attendees at the International

Society of Hair Restoration Surgery Meeting. Las Vegas: September 5-8, 1995. 119. Haber RS. Advanced hair photography Workshop. Presented to conference attendees at the International Society

of Hair Restoration Surgery Meeting. Las Vegas: September 5-8, 1995. 120. Haber RS. A simplified approach to strip length determination. Presented to conference attendees at the

International Society of Hair Restoration Surgery Meeting. Las Vegas: September 5-8, 1995. 121. Haber RS. Accurate estimation of hair transplant graft requirements- Introduction of the Trichoscope. Presented

to conference attendees at the American Academy of Dermatology Meeting. New Orleans: February 1995. 122. Haber RS. A new device for taking great Polaroid photos. Presented to conference attendees at the American

Academy of Dermatology Meeting. New Orleans: February 1995. 123. Haber RS. A new approach to the frontal nerve block for hair transplantation. Presented to conference attendees

at the American Academy of Dermatology Meeting. New Orleans: February 1995. 124. Haber RS. Childhood skin disorders: what the pediatrician needs to know. Presented at the Rainbow Babies and

Children’s Hospital, Pediatrics Today Conference. Cleveland: December 13, 1994. 125. Haber RS. A new method for graft count estimation in total micrografting- Introduction of the Trichoscope.

Presented to conference attendees at the International Society of Hair Restoration Surgery Meeting. Toronto: September 9-11, 1994.

126. Haber RS. Let’s standardize hair restoration photography. Presented to conference attendees at the International

Society of Hair Restoration Surgery Meeting. Toronto: September 9-11, 1994. 127. Haber RS. Getting the picture- Photography for hair transplantation. Presented to conference attendees at the

International Society of Hair Restoration Surgery Meeting. Toronto: September 9-11, 1994. 128. Haber RS. Photography Workshop. Presented to conference attendees at the International Society of Hair

Restoration Surgery Meeting. Toronto: September 9-11, 1994. 129. Haber RS. Nerve block anesthesia for hair transplant surgery. Presented to conference attendees at the American

Academy of Dermatology Meeting. Washington, D.C.: December 1993. 130. Haber RS. A refined method of donor harvesting. Presented to conference attendees at the American Academy of

Dermatology Meeting. Washington, D.C: December 1993. 131. Haber RS. Update on Langerhans Cell Histiocytosis. Presented at the University Hospitals of Cleveland

Department of Dermatology Conference. Cleveland: August 1992. 132. Haber RS. Dermatologic Photography. Presented at the University Hospitals of Cleveland Department of

Dermatology Conference. Cleveland: March 1992.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

15

133. Haber RS. Annular Erythema of Infancy. Presented to conference attendees at the American Academy of

Dermatology Meeting. Dallas: December 1991. 134. Haber RS. Update on the Ichthyoses. Presented at the University Hospitals of Cleveland Department of

Dermatology Conference. Cleveland: March 1991. 135. Haber RS. Report of a cutaneous manifestation of congenital lymphangiectasis. Presented to conference attendees

at the American Academy of Dermatology Meeting. Atlanta: December 1990. 136. Haber RS. Topical anti-androgens in the treatment of male pattern baldness and acne. Presented to conference

attendees at the New York University Advances in Dermatology Conference. New York: April 1990.

CLINICAL RESEARCH ACTIVITIES

1. Principal Investigator, A Randomized, Double Blind, Multiple Site, Placebo Controlled, Parallel-Design, Clinical study to evaluate the therapeutic equivalence of Confidential to Confidential in patients with Actinic Keratosis on the face or balding scalp. August 2015-Present, Sponsor: Confidential

2. Principal Investigator, A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study

to Compare Confidential to Confidential, and Both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis on the Head Region (Face or Scalp). March 2015 – Present Sponsor: Confidential

3. Principal Investigator, A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Confidential per Day of Confidential Compared to Placebo in the Treatment of Acne Vulgaris. October 2014 – Present Sponsor: Confidential

4. Sub-Investigator, A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of Confidential in Subjects with mild to Moderate Alzheimer’s Disease. August 2014 – Present Sponsor: Confidential

5. Principal Investigator, A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study Comparing a Generic Confidential, Confidential to Reference Listed Drug Confidential, Confidential and Both Active Treatments to a Vehicle Control in the Treatment of Plaque Psoriasis. June 2014 – Present Sponsor: Confidential

6. Principal Investigator, A randomized, double-blind, parallel-group, vehicle-controlled, multicenter study comparing Confidential (Confidential) to Confidential (Confidential) (Confidential) in the treatment of actinic keratosis of the face or bald scalp. April 2014 – July 2015 Sponsor: Confidential

7. Principal Investigator, A Phase 2, randomized, double-blind, vehicle controlled, comparator study of the effect of Confidential and Confidential in subjects with axillary hyperhidrosis. February 2014 – January 2015 Sponsor: Confidential

8. Principal Investigator, A follow up evaluation of study subjects treated in protocol Confidential, the Phase 3 Double-blind, randomized, parallel group study evaluating the efficacy and safety of Confidential in patients with severe recalcitrant nodular acne. October 2013 – May 2014 Sponsor: Confidential

9. Principal Investigator, A randomized, double blind, vehicle controlled, multicenter, parallel group study of the Safety of Confidential versus Confidential and the efficacy of Confidential versus vehicle spray in the treatment of moderate plaque psoriasis. January 2014 – January 2015 Sponsor: Confidential

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

16

10. Principal Investigator, A multicenter, double blind, randomized, parallel group, vehicle controlled Phase 3 study to compare the safety and efficacy of Confidential to vehicle in patients with acne vulgaris. January 2014- January 2015 Sponsor: Confidential

11. Principal Investigator, double blind, multicenter, placebo controlled, parallel design study comparing Confidential and Confidential and Confidential in the treatment of acne vulgaris. February 2014 – November 2014 Sponsor: Confidential

12. Principal Investigator, A double blind, multicenter, vehicle controlled study of the efficacy and safety of Confidential administered for the treatment of lice infestation. February 2014 – August 2014 Sponsor: Confidential

13. Principal Investigator, A multi-center, randomized, double-blind, parallel group vehicle active controlled study

to compare the efficacy and safety of Confidential/ Confidential topical gel versus topical gel vehicle in subjects

with acne vulgaris September 2013 – February 2014 – Sponsor: Confidential

14. Principal Investigator, Phase 3 trial comparing once daily treatment with Confidential with Confidential plus

Confidential with vehicle in subjects with psoriasis vulgaris. June 2013 – January 2014 – Sponsor: Confidential

15. Principal Investigator, Phase 3, A Placebo and Confidential Controlled study to evaluate the efficacy and safety

of the Induction and Maintenance Regimens of Confidential in subjects with Moderate to Severe Plaque Psoriasis. March 2013- Present – Sponsor: Confidential

16. Principal Investigator, Phase 3, Double-blind, Randomized, Parallel –group, Vehicle-controlled, Multicenter

Study Comparing: Confidential and: Confidential Generic to Reference listed drug in the treatment of Acne Vulgaris. January 2013 – February 2014 – Sponsor: Confidential

17. Principal Investigator, Phase 3, Double-blind, Placedo Controlled, Parallel Design, Multiple Site, Clinical Study

to evaluate the Bioequivalence of Two : Confidential formulations in patients with Actinic Keratosis. January 2013 – October 2013 – Sponsor: Confidential

18. Principal Investigator, Phase 3, Double-blind, Randomized, Parallel-group, vehicle-controlled, Multicenter

study comparing Confidential to reference listed drug in the treatment of Rosacea January 2013 – February 2014 Sponsor: Confidential

19. Principal Investigator, A Randomized, Double-Blind, Parallel-Group, vehicle – controlled, Multicenter study

Comparing Confidential to Confidential in the treatment of Actinic Keratosis of the face or balding scalp. August 2012- January 2013- Sponsor: Confidential

20. Principal Investigator, A Double – Blind Randomized, Parallel-group, vehicle-controlled, Multicenter Study

comparing Confidential and Confidential to Reference Listed Drug in the treatment of Acne Vulgaris. July 2012- April 2013 -Sponsor: Confidential

21. Principal Investigator,Phase 3 Randomized, double-blind, 12-week vehicle-controlled, parallel-group study

assessing the efficacy and safety of Confidential cream versus vehicle cream in subjects with papulopustular rosacea, followed by a 40-week investigator-blinded extension comparing the long-term safety of Confidential cream Confidential Feb 2012-August 2013- Sponsor: Confidential

22. Principal Investigator, A Randomized, Phase 2, Double-Blind, Placebo-Controlled Trial to

Evaluate the Safety and Efficacy of Confidential Gel in Adult Patients with Mild to Moderate Atopic Dermatitis. Feb 2012-August 2013-Sponsor: Confidential

23. Principal Investigator, A Randomized, Placebo-controlled Phase IIb Study to Evaluate the Efficacy, Safety and

Tolerability of Confidential Topical when applied twice daily in subjects with Psoriasis Vulgaris.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

17

Jan 2012- February 2013– Sponsor: Confidential

24. Principal Investigator, A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Confidential in Subjects with Moderate to Severe Acne Vulgaris. Jan 2012 - February 2013 Sponsor: Confidential

25. Principal Investigator, A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study Comparing Confidential to Confidential and Both Active Ingredients to Confidential in the Treatment of Mild to Severe Acne Vulgaris. July 2011-October 2012 –Sponsor: Confidential

26. Principal Investigator, A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study of the Safety and Efficacy of Confidential and Confidential in Subjects with Interdigital Tinea Pedis. July 2011-November 2012 Sponsor: Confidential

27. Principal Investigator, A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel Group

Study Comparing the Efficacy and Safety Confidential versus Placebo and Confidential in the Treatment of Inflammatory Lesions in Subjects with Acne Vulgaris. June 2011-November 2012 Sponsor Confidential.

28. Principal Investigator, A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to

Demonstrate the Efficacy and Assess the Safety of Confidential Applied Topically Once Daily in Subjects with Moderate to Severe Facial Erythema Associated with Rosacea. June 2011- February 2012 Sponsor: Confidential

29. Principal Investigator, A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the

Efficacy and Safety of Confidential vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenails in Adults. March 2011-December 2012 Sponsor: Confidential

30. Principal Investigator, Confidential topical suspension compared to Confidential in the topical suspension vehicle, Confidential in the topical suspension vehicle and the topical suspension vehicle alone in psoriasis vulgaris. September 2010-March 2012 Sponsor: Confidential

31. Principal Investigator, A multi-center, randomized, vehicle controlled, double-blind study to evaluate the safety and efficacy of Confidential administered once daily for the treatment of subjects 9 to 11 years of age with acne vulgaris. June 2010-September 2011 Sponsor: Confidential

32. Principal Investigator, A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Safety and

Efficacy of Confidential Topical Solution versus Vehicle in Subjects with Mild to Moderate Onychomycosis of the Toenails. December 2009-March 2011- Sponsor: Confidential

33. Principal Investigator, A Double-Blind, Randomized, Phase III, Parallel Group Study Evaluating The Efficacy

and Safety of Confidential In Patients With Severe Recalcitrant Nodular Acne. October 2009 – October 2011 Sponsor: Confidential

34. Principal Investigator, A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Parallel Group Study To Compare Confidential, Confidential to Confidential (Confidential), and both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris. October 2009 – April 2011 Sponsor: Confidential

35. Principal Investigator, A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Parallel Group Study To Evaluate The Safety and Efficacy of Confidential In Subjects With Acne Vulgaris. October 2009 – October 2011 Sponsor: Confidential

36. Principal Investigator, A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy, Safety And Tolerability of Confidential in Adults with a Diagnosis of Atopic Dermatitis (AD) with Moderate to Very Severe Pruritus. May 2009 – May 2011 Sponsor: Confidential

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

18

37. Principal Investigator, A Phase 4, Open-Label, Multicenter, Community-based, 12-Week Trial Assessment of Effectiveness, Safety, and Subject Satisfaction with Confidential When Used as Monotherapy or as Add-On Therapy to Existing Topical regimens for the Treatment of Rosacea. May 2009- July 2009 Sponsor: Confidential

38. Principal Investigator, A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Evaluate the Clinical Bioequivalence of Confidential % to Confidential and Superiority over Vehicle Cream in the Treatment of Multiple Actinic Keratoses. February 2009 –July 2009 Sponsor: Confidential

39. Principal Investigator, A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Confidential (Confidential) and Confidential and Compare Both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis. February 2009 –June 2009 Sponsor: Confidential

40. Principal Investigator, A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Clinical Study to Evaluate the Bioequivalence of Two Confidential Formulations in Patients with Moderate to Severe Atopic Dermatitis. October 2008-April 2009 Sponsor: Confidential

41. Principal Investigator, A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Confidential in Subjects with Tinea Pedis. September 2008-Augist 2009 Sponsor: Confidential

42. Principal Investigator, A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group

Evaluation of the Efficacy and Safety of Confidential in Subjects with Tinea Cruris. September 2008-Augist 2009 Sponsor: Confidential

43. Principal Investigator, A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study Comparing generic Confidential (Confidential.) to Confidential (Confidential) Confidential and both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris. September 2008-Augist 2009 Sponsor: Confidential

44. Principal Investigator, A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Confidential Confidential to Confidential and Both Active Treatments to a Vehicle Control in the Treatment of Atopic Dermatitis. June 2008-October 2008 Sponsor: Confidential

45. Principal Investigator, A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Generic Confidential to Confidential (Confidential) and both Active Treatments to a Vehicle Control in the Treatment of Actinic Keratosis of the Face and Scalp. June 2008-February 2009 Sponsor: Confidential

46. Principal Investigator, Development and Validation of a Patient-Reported Alopecia Efficacy Measure and Modification of the Women’s Androgenetic Alopecia Quality of Life Questionnaire. January 2008-March 2008 Sponsor: Confidential

47. Principal Investigator, A Multicenter, Randomized, Double Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Confidential Compared with Vehicle Lotion in Subjects with Acne Vulgaris. September 2007-February 2008 Sponsor: Confidential

48. Principal Investigator, A Comparative Safety and Efficacy Study between Confidential and Confidential In

Subjects ≥6 Months of Age with Pediculosis Capitis. September 2007-April 2008 Sponsor: Confidential

49. Principal Investigator, A Randomized, Double Blind, Placebo Controlled, Parallel Design, Clinical Study to Evaluate the Bioequivalence Confidential Compared to Confidential (Confidential) in Patients with Acne Vulgaris.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

19

June 2007-January 2008 Sponsor: Confidential

50. Principal Investigator, APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Confidential for the Treatment of Atopic Dermatitis.June 2007-Present Sponsor: Confidential

51. Principal Investigator, A Randomized, Double Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Evaluate the Bioequivalence of Confidential (Confidential) to Confidential (Confidential) in Patients with Moderate to Severe Plaque Psoriasis. April 2007-January 2008 Sponsor: Confidential

52. Principal Investigator, A Prospective 10 Year Registry of Pediatric Subjects (age ≥2 years to ≤17 years) With Atopic Dermatitis Who Have Used Confidential (Confidential.) April 2007-Present Sponsor: Confidential

53. Principal Investigator, A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Confidential to Confidential and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris. February 2007-February 2008 Sponsor: Confidential

54. Principal Investigator, A Phase IV, Open-Label, Community-based, 4 Week Trial Assessing Efficacy, Tolerance to Treatment, and Patient Satisfaction with Confidential Spray, 0.05% when Used as Monotherapy or as Add-on Therapy to Existing Systemic or Topical Anti-psoriatic Agents for the Treatment of Moderate to Sever Plaque Psoriasis. February 2006 – June 2006. Sponsor: Confidential

55. Principal Investigator, A randomized sequential group-dose escalation double-blind trial of topically applied tacrolimus vs. vehicle in three to six year old children with atopic dermatitis. July 1996 - 2000. Co-investigator: Kevin Cooper, M.D. Sponsor: Fujisawa

56. Co-investigator, A phase IV trial to evaluate the efficacy and safety of PUVA (psoralen and UVA light) in

patients with psoriasis not adequately responsive to steroid therapy. August 1993-June 1994. Co-investigator: Dow Stough, M.D. Sponsor: ICN Pharmaceuticals

57. Research associate, evaluation of 6 weeks and 12 weeks treatment with Lamisil (250mg daily) vs. placebo in the

treatment of onychomycosis of the fingernails. February 1993-June 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Sandoz Pharmaceuticals Corp.

58. Research associate, evaluation of 12 weeks and 24 weeks treatment with Lamisil (250mg ) vs. placebo in the

treatment of onychomycosis of the toenails. October 1992-June 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Sandoz Pharmaceuticals Corp.

59. Research associate, evaluation of topical 0.1 % isotretinoin cream for the treatment of patients with

photodamaged skin. October 1992-June 1993. Principal investigator: David R. Bickers, M.D. Sponsor: Hoffman-La Roche Inc.

60. Research associate, evaluation of 1% terbenifine (Lamisil) cream with Lamisil cream vehicle in the treatment of tinea pedis, plantar lesions (moccasin type). August 1992-December 1992. Principal investigator: Boni E. Elewski, M.D. Sponsor: Sandoz Pharmaceuticals Corp.

61. Research associate, evaluation of 1% terbenifine (Lamisil) cream with Lamisil cream vehicle in the treatment of

tinea pedis, interdigital type. September 1992-February 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Sandoz Pharmaceuticals Corp.

62. Research associate, evaluation of Loceryl (Ro 14-4767, Amorolfine) nail lacquer 5%. August 1992-June 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Hoffman-La Roche Inc

63. Research associate, evaluation of itraconazole capsules (R51211) for the treatment of onychomycosis of the

toenail. July 1992-June 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Janssen Research Foundation

64. Research associate, evaluation of 1% Terbinafine cream with 1% clotrimazole cream in the treatment of tinea

pedis (interdigital type) athlete's foot. September 1991-April 1992.

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

20

Principal investigator: Boni E. Elewski, M.D. Sponsor: Sandoz Pharmaceuticals

65. Research associate, evaluation of oxiconazole nitrate, 1% - fluticasone propionate, 0.05%, combination cream, 1% in the treatment of inflammatory tinea pedis. June 1991-February 1992. Principal investigator: Boni E. Elewski, M.D. Sponsor: Glaxo Inc.

66. Research associate, evaluation of oral Acyclovir to oral 256U87 for the treatment of herpes zoster in

immunocompetent patients 50 years and older. April 1991-February 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Burroughs Wellcome

67. Research associate, evaluation of oral Acyclovir to oral 256U87 for the treatment of herpes zoster in immunocompetent patients under 50 years. April 1991-February 1993. Principal investigator: Boni E. Elewski, M.D. Sponsor: Burroughs Wellcome

68. Research associate, evaluation of Calcipotriol (MC903/BMY 30434) ointment (0.005%) in the long-term treatment of plaque psoriasis. March 1991-July 1992. Principal investigator: Teri A. Kahn, M.D. Sponsor: Bristol-Myers Squibb

69. Research associate, evaluation of BMY 30123 (0.3%) cream, its vehicle and Retin-A (0.1%) cream in the treatment of facial acne vulgaris. February 1991-December 1991. Principal investigator: Boni E. Elewski, M.D. Sponsor: Bristol-Myers Squibb

70. Research associate, evaluation of Sandimmune as therapy for patients with severe recalcitrant psoriasis. September 1991-July 1992. Principal investigator: David R. Bickers, M.D. Sponsor: Sandoz Pharmaceuticals

71. Research associate, evaluation of Sulconazole nitrate/steroid antifungal. July 1990-November 1990. Principal investigator: Boni E. Elewski, M.D. Sponsor: Bristol-Myers

72. Research associate, evaluation of 5% Amorolfine (Ro 14-4767, Loceryl™) nail lacquer applied twice a week to patients with onychomycosis. July 1990-October 1991. Principal investigator: David R. Bickers, M.D. Sponsor: Hoffman-La Roche

73. Research associate, evaluation of Lonapolene ointment 1% vs. vehicle in treating psoriasis vulgaris. April 1990-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Syntex Research

74. Research associate, evaluation of recombinant human basic fibroblast growth factor in the treatment of venous stasis and diabetic ulcers. January 1990-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Pharmaco Dynamics Research

75. Research associate, evaluation of ciclopirox (0.77%)/triamcinolone acetonide (0.1%) cream vs. ciclopirox vs. triamcinolone in patients with tinea cruris. September 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Hoechst-Roussel

76. Research associate, evaluation of Timunox (Thymopentin) injections in patients with severe atopic dermatitis. September 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Immunobiology Research Institute

77. Research associate, evaluation of Inocoterone Acetate (RU 882) vs placebo in male patients with acne vulgaris.

August 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Hoechst-Roussel

78. Research associate, evaluation of the effect of Acitretin (Ro 1670) on psoriasis. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Hoffman-La Roche

Curriculum Vitae Robert S. Haber, MD

October 2, 2019

21

79. Research associate, evaluation of Itraconazole capsules vs. placebo in the treatment of tinea corporis and tinea cruris. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Study completed with Janssen Pharmaceutica

80. Research associate, evaluation of Itraconazole capsules vs. placebo in the treatment of cutaneous candidiasis. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Janssen Pharmaceutica

81. Research associate, evaluation of continuation of Rogaine topical solution in patients with female androgenic alopecia. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Upjohn Pharmaceuticals

82. Research associate, evaluation of cyclosporin for patients with cyclosporin induced remissions of severe psoriasis. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Sandoz Research Institute

83. Research associate, assessment of photodamaged skin treated with topical Ro 15-1570. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Hoffman-La Roche

84. Research associate, tissue characterization of skin with ultrasound. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Riverside Research

85. Research associate, identification and enumeration of T cell subpopulations and antigen presenting cells in psoriatic plaques in patients treated with Cyclosporin A. July 1989-July 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Sandoz Research Institute.

86. Research associate, evaluation of pulsed electromagnetic leg ulcer therapy (PELUT) system for recalcitrant leg ulcers. July 1989-April 1990. Principal investigator: Jerome L. Shupack, M.D. Sponsor: Healing Enhancement Technologies.

87. Research associate, open-label study of 0.01% tretinoin cream for long-term therapy of skin aging. July 1989-March 1990. Principal investigator: Jerome L. Shupack, M.D. Study completed with Ortho Pharmaceuticals.

88. Research associate, evaluation of Loprox nail lacquer 8% vs. placebo in the treatment of onychomycosis of the fingernails. July 1989-January 1990. Principal investigator: Jerome L. Shupack, M.D. Study completed with Hoechst-Roussel.